Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Michael Heneghan MD, MMedSc, FRCPI

Michael A. Heneghan MD, MMedSc, FRCPI

Consultant Hepatologist; Professor of Hepatology; Corporate Medical Director for Strategy; Clinical Director for Cancer Services, King's College Hospital NHS Foundation Trust, London, United Kingdom

Disclosures

Michael A. Heneghan is supported by the European Association for the Study of the Liver Registry Grant (Liver Disease in Pregnancy), The King’s College Hospital NHS Trust Charity (Orpin Bequest), and The Kelly Group.

Michael A. Heneghan consults for Ipsen. He is on the speakers’ bureaus for Advanz and Falk. 

Recent Contributions to PracticeUpdate:

  1. Factors Associated With Treatment Response and Clinical Event-Free Survival in Patients With Autoimmune Hepatitis

Most Read This Week

Recently Updated